Development of a novel PROTAC using the nucleic acid aptamer as a targeting ligand for tumor selective degradation of nucleolin
PROteolysis TArgeting Chimeras (PROTACs) induce targeted protein degradation by hijacking the intracellular ubiquitin proteasome system, thus emerging as a new strategy for drug development. However, most PROTACs generated lack cell-type selectivity and are poorly soluble in water. To address this d...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2022-12-01
|
| Serier: | Molecular Therapy: Nucleic Acids |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S2162253122002517 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
